首页> 外国专利> tool for the transfer and the characteristic of proteins with the pseudomonas type iii secretion system

tool for the transfer and the characteristic of proteins with the pseudomonas type iii secretion system

机译:假单胞菌Ⅲ型分泌系统的蛋白质转移和特征分析工具

摘要

Expression vector (EV) for a chimeric protein (CP) the N-terminal fragment of which corresponds to a fusion between the N-terminus of ExoS of Pseudomonas aeruginosa and an amino acid (aa) sequence of interest (I), with the N-terminus of ExoS being the N-terminus of CP. EV comprises (5' to 3') a promoter; sequence (II) that encodes 48-96 N-terminal aa of ExoS (or of a sequence with at least 70% identity) and sequence (III) that encodes (I), is new. Independent claims are also included for: (1) cloning vector (CV) containing, 5' to 3', a promoter and (II); (2) CP in which the N-terminus comprises the first 48-96 aa from the N-terminus of ExoS, or a sequence with at least 70% identity; (3) gene encoding the CP of (2); (4) isolated strain of P. aeruginosa transformed with EV; (5) ex vivo or in vitro injection of CP into eukaryotic cells; and (6) producing CP. ACTIVITY : Cytostatic, Antiinflammatory; Antiangiogenic; Antioxidant. No biological data given. MECHANISM OF ACTION : None given.
机译:嵌合蛋白(CP)的表达载体(EV),其N端片段对应于铜绿假单胞菌(Pseudomonas aeruginosa)ExoS的N端与目标氨基酸(I)序列(N)的融合体ExoS的末端是CP的N末端。 EV包含(5'至3')启动子;编码ExoS(或具有至少70%同一性的序列)的48-96个N末端氨基酸的序列(II)和编码(I)的序列(III)是新的。还包括以下方面的独立权利要求:(1)含有5'至3'启动子和(II)的克隆载体(CV); (2)CP,其中N末端包含来自ExoS N末端的第一个48-96 aa,或具有至少70%同一性的序列; (3)编码(2)的CP的基因; (4)分离的用EV转化的铜绿假单胞菌菌株; (5)将CP离体或体外注射到真核细胞中; (6)生产CP。活性:细胞抑制,抗炎;抗血管生成;抗氧化剂。没有给出生物学数据。作用机理:未给出。

著录项

  • 公开/公告号DE602004025139D1

    专利类型

  • 公开/公告日2010-03-04

    原文格式PDF

  • 申请/专利权人 UNIVERSITE JOSEPH FOURIER;

    申请/专利号DE20046025139T

  • 申请日2004-11-04

  • 分类号C07K14/21;C07K19/00;C12N1/21;C12N15/62;C12N15/78;

  • 国家 DE

  • 入库时间 2022-08-21 18:27:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号